Drug Repositioning: Joel Dudley of NuMediiSubmitted by Theral Timpson on Tue, 11/08/2011 - 23:36
Podcast Sponsor: Ingenuity - The fastest way to get biological meaning from your expression data. Get a free iReport
Guest: Joel Dudley, Ph D, Co-founder, NuMedii Bio and Contact Info
(Place marker at the following time markers.)
1:12 - What is drug repositioning?
4:51 - A few guys and a computer can be a pharma company
8:00 - Model of service
13:25- First company set up to do this
20:25- Spin-off from Stanford
27:24- Personal journey to Silicon Valley
33:24- 'Open science'
40:04- Exploring Personal Genomics
41:54- How far can computers take us?
Joel Dudley is a co-founder of NuMedii, a spin-off from Atul Butte's lab at Stanford. The new bioinformatics company has developed proprietary software to find new uses for existing or retired drugs. The company accesses a great amount of public and private data on both drug compounds and disease targets to come up with a Network of Efficacy.
Joel is from a small town in Wisconsin. He talks about his journey to Silicon Valley.